Development and validation of a pediatric pharmacological readiness assessment scale for recurrent respiratory infections.

Abstract

To develop and validate a Pediatric Pharmacological Readiness Assessment Scale for recurrent respiratory infections, focusing on medication adherence, caregiver pharmacological knowledge, and pharmacist-led interventions. An initial scale was constructed through literature review, expert consultation, and a pilot survey, guided by the Pharmaceutical Care Practice Model. A convenience sample of 156 primary caregivers of children hospitalized for recurrent respiratory infections was surveyed between April 2023 and April 2024. Item analysis and reliability and validity testing were conducted. The final scale includes 34 items across seven dimensions: child's condition, parental condition, pharmacological knowledge, medication attitudes, adherence behavior, coping ability, and anticipated support. The overall Cronbach's α was 0.934, with split-half reliability at 0.826. Dimensional Cronbach's α values ranged from 0.834 to 0.925, and split-half reliability from 0.819 to 0.957. Content validity indices (I-CVI: 0.835 - 1.000; S-CVI: 0.902) were high. Exploratory factor analysis identified seven factors explaining 73.617% of variance. The scale demonstrates good reliability and validity, accurately reflecting pharmacological readiness. It is a valuable tool for clinical pharmacists to enhance discharge preparedness, improve medication adherence, and reduce readmissions.